Author: anomaly

Nature – Volume 586 – Alexandra Sinclair: Easing the Pressure

Emerging Stocks Down Under

Momentum builds for small cap biotechs

Post-placement indigestion an opportunity?

Bioshares – Edition 844 – Invex Therapeutics

The Market Herald – Invex taps investors for $26.2m after positive Exenatide trials

The West Australian – Biotech fires on Twiggy’s 11.8pc stake

Small Caps – Invex raises $26 million as it plans for Phase III clinical trial

Biotech Daily – Dr Boreham’s Crucible – Why Invex has all the right ingredients to possibly become a takeover target

Birmingham researcher awarded £1.68m to fund research in ‘raised brain pressure’